HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Union For Ethical BioTrade Invites Comment On Draft Standard

This article was originally published in The Rose Sheet

Executive Summary

The Union for Ethical BioTrade is soliciting comment on proposed changes to its Ethical BioTrade Standard based on input from stakeholders, including the broadening of its scope to cover all natural ingredients rather than merely “native” natural ingredients.

You may also be interested in...



Consumers Cloudy On Biodiversity Issue As Movement Grows Across Globe

Consumers around the world are growing increasingly familiar with the term “biodiversity,” but that doesn’t mean they know what it is.

Global Biodiversity Pact’s Potential Impact On Personal Care Still Unclear

Six months after the adoption of the Nagoya Protocol – an international treaty conceived to help ensure fairness in the way genetic resources are mined for research and development purposes – the extent to which the personal-care industry will be impacted is still not entirely clear.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS017700

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel